Bioventus (BVS) Short term Debt (2020 - 2026)

Bioventus (BVS) has reported Short term Debt for 7 consecutive years, with $18.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Short term Debt fell 56.76% year-over-year to $18.8 million; the trailing twelve-month figure through Jun 2026 stood at $18.8 million (down 56.76% YoY), and the FY2025 full-year result was $15.0 million, down 45.13% from the prior year.
• Short term Debt held at $18.8 million in Q2 2026 per BVS's latest filing, from $18.8 million in the prior quarter.
• Across five years, Short term Debt topped out at $43.4 million in Q2 2025 and bottomed at $11.2 million in Q3 2025.
• Historically, Short term Debt has averaged $27.3 million across 5 years, with a median of $27.6 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Short term Debt jumped 240.69% in 2024, then tumbled 70.83% in 2025.
• Over 5 years, Short term Debt stood at $33.1 million in 2022, then dropped by 15.76% to $27.8 million in 2023, then fell by 1.83% to $27.3 million in 2024, then sank by 45.13% to $15.0 million in 2025, then increased by 25.0% to $18.8 million in 2026.
• According to Business Quant data, Short term Debt over the past three periods registered $18.8 million, $18.8 million, and $15.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.